New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2014
08:05 EDTKERXKeryx announces marketing approval of ferric citrate in Japan
Keryx announced that its Japanese partner, Japan Tobacco has received manufacturing and marketing approval of ferric citrate from the Japanese Ministry of Health, Labour and Welfare. Under the license agreement with JT and Torii, within 30 days, Keryx will receive a non-refundable payment of $10M for the achievement of the marketing approval milestone. Keryx will also receive double-digit tiered royalties on net sales of Riona in Japan, as well as up to an additional $55M upon the achievement of certain annual net sales milestones.
News For KERX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 26, 2015
08:48 EDTKERXKeryx management to meet with JMP SEcurities
Subscribe for More Information
March 23, 2015
13:43 EDTKERXKeryx mentioned cautiously in a Seeking Alpha Pro article
Subscribe for More Information
March 20, 2015
07:55 EDTKERXKeryx survey results positive, says Oppenheimer
After surveying 50 nephrologists/nurses/dietitians at U.S. dialysis clinics, Oppenheimer reported that dialysis providers it surveyed expect to prescribe Keryx's Auryxia in 11% of new starts and about 12% of switchers . As a result of this data points and other data from the survey, the firm expects Auryxia prescription trends to improve. It keeps an $18 price target and Outperform rating on the shares.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use